نتایج جستجو برای: amyloid aβ

تعداد نتایج: 40212  

2011
Xiang Yu Jie Zheng

BACKGROUND Misfolding and self-assembly of Amyloid-β (Aβ) peptides into amyloid fibrils is pathologically linked to the development of Alzheimer's disease. Polymorphic Aβ structures derived from monomers to intermediate oligomers, protofilaments, and mature fibrils have been often observed in solution. Some aggregates are on-pathway species to amyloid fibrils, while the others are off-pathway s...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2017
Jay Rasmussen Jasmin Mahler Natalie Beschorner Stephan A Kaeser Lisa M Häsler Frank Baumann Sofie Nyström Erik Portelius Kaj Blennow Tammaryn Lashley Nick C Fox Diego Sepulveda-Falla Markus Glatzel Adrian L Oblak Bernardino Ghetti K Peter R Nilsson Per Hammarström Matthias Staufenbiel Lary C Walker Mathias Jucker

The molecular architecture of amyloids formed in vivo can be interrogated using luminescent conjugated oligothiophenes (LCOs), a unique class of amyloid dyes. When bound to amyloid, LCOs yield fluorescence emission spectra that reflect the 3D structure of the protein aggregates. Given that synthetic amyloid-β peptide (Aβ) has been shown to adopt distinct structural conformations with different ...

2016
Pinaki Misra Ravindra Kodali Saketh Chemuru Karunakar Kar Ronald Wetzel

Since early oligomeric intermediates in amyloid assembly are often transient and difficult to distinguish, characterize and quantify, the mechanistic basis of the initiation of spontaneous amyloid growth is often opaque. We describe here an approach to the analysis of the Aβ aggregation mechanism that uses Aβ-polyglutamine hybrid peptides designed to retard amyloid maturation and an adjusted th...

2011
Susann Cattepoel Michael Hanenberg Luka Kulic Roger M. Nitsch

Amyloid-beta peptide (Aβ)-directed active and passive immunization therapeutic strategies reduce brain levels of Aβ, decrease the severity of beta-amyloid plaque pathology and reverse cognitive deficits in mouse models of Alzheimer's disease (AD). As an alternative approach to passive immunization with full IgG molecules, single-chain variable fragment (scFv) antibodies can modulate or neutrali...

Journal: :Alzheimers & Dementia 2023

Background Abnormal amyloid-β (Aβ) deposition in the brain has been defined as earliest pathological change of Alzheimer disease (AD). We combined immunoprecipitation (IP) with MALDI-TOF MS to develop IP-MALDI-MS, which is an analytical technique for plasma Aβ. This previously revealed that APP669-711/Aβ1-42 ratio, Aβ1-40/Aβ1-42 and a combination these two biomarkers (a composite biomarker) hum...

2016
Francis T. Hane Reid Hayes Brenda Y. Lee Zoya Leonenko Eugene A. Permyakov

The presence of trace concentrations of metallic ions, such as copper and zinc, has previously been shown to drastically increase the aggregation rate and neurotoxicity of amyloid-β (Aβ), the peptide implicated in Alzheimer's disease (AD). The mechanism of why copper and zinc accelerate Aβ aggregation is poorly understood. In this work, we use single molecule force spectroscopy (SMFS) to probe ...

2010
Weiming Xia

The development of amyloid-containing neuritic plaques is an invariable characteristic of Alzheimer's diseases (AD). The conversion from monomeric amyloid β protein (Aβ) to oligomeric Aβ and finally neuritic plaques is highly dynamic. The specific Aβ species that is correlated with disease severity remains to be discovered. Oligomeric Aβ has been detected in cultured cells, rodent and human bra...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2013
John R Walker Reynand Pacoma James Watson Weijia Ou Juliano Alves Daniel E Mason Eric C Peters Hugo D Urbina Gus Welzel Alana Althage Bo Liu Tove Tuntland Laura H Jacobson Jennifer L Harris Andrew M Schumacher

Accumulation of β-amyloid (Aβ) in the brain is believed to contribute to the pathology of Alzheimer's Disease (AD). Aβ levels are controlled by the production of Aβ from amyloid precursor protein, degradation by proteases, and peripheral clearance. In this study we sought to determine whether enhancing clearance of plasma Aβ with a peripherally administered Aβ-degrading protease would reduce br...

Journal: :Expert opinion on medical diagnostics 2011
Geoffrey A Kerchner

INTRODUCTION Biomarkers for Alzheimer's disease (AD) may facilitate early and accurate diagnosis and offer a way to track the effectiveness of new therapies. Amyloid imaging offers an unrivaled ability to visualize the presence and anatomical distribution of fibrillar beta-amyloid (Aβ) pathology non-invasively in living humans. New diagnostic criteria for AD incorporate the use of such biomarke...

2017
Young-Ji Shiao Muh-Hwan Su Hang-Ching Lin Chi-Rei Wu

Acteoside and isoacteoside, two phenylethanoid glycosides, coexist in some plants. This study investigates the memory-improving and cytoprotective effects of acteoside and isoacteoside in amyloid β peptide 1-42 (Aβ 1-42)-infused rats and Aβ 1-42-treated SH-SY5Y cells. It further elucidates the role of amyloid cascade and central neuronal function in these effects. Acteoside and isoacteoside ame...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید